Veru Inc. (NASDAQ:VERU) Q4 2022 Earnings Conference Call December 5, 2022 8:00 AM ET Company Participants Sam Fisch - Executive Director, Investor Relations, and Corporate Communications Mitchell Steiner - Chairman, Chief Executive Officer and President Michele Greco - Chief Financial Officer and Chief Administrative Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Leland Gershell - Oppenheimer Chris Howerton - Jefferies Yi Chen - H.C. Wainwright Operator Good morning, ladies and gent ...

Veru Inc. Nasdaq:VERU | --- | --- | --- | --- | |---------------------------------------------------------------------------------------------------|-------|-------|-------| | | | | | | | | | | | Biopharmaceutical Company focused on Infectious Disease and Oncology | | | | | Veru Corporate Presentation Cantor Oncology, Hematology & HemeOnc Conference September 28, 2022 | | | | Forward looking statements The statements in this release that are not historical facts are "forward-looking statements" as that term ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) Commission File Number 1-13602 Veru Inc. (Exact Name of Registrant as Specified in its Charter) Wisconsin 39-1144397 (Registrant's Telephone Number, Including Area Code) N/A (Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report) Securities registered pursuant to Section 12(b) of the Act: 2916 N. Miami Avenue, Suite 1000, Miami, FL 33127 (Address of Principal Executive Offices) (Zip Code) ...

Veru Inc. (NASDAQ:VERU) Q3 2022 Earnings Conference Call August 11, 2022 8:00 AM ET Company Participants Samuel Fisch - Executive Director, IR & Corporate Communications Mitchell Steiner - Chairman, President & CEO Michele Greco - CFO & Chief Administrative Officer Gary Barnette - Chief Scientific Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Leland Gershell - Oppenheimer Chris Howerton - Jefferies Yi Chen - H.C. Wainwright Operator Good morning, ladies and gentlemen, and welcome t ...

Veru Inc. Nasdaq:VERU | --- | --- | --- | --- | |-------|-------|-------|-------| | | | | | | | | | | | | | | | Forward looking statements The statements in this release that are not historical facts are "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this release include statements regarding: whether and when the Company will submit an EUA application, or receive an emergency use authorization or any approval from F ...

Veru Inc. Nasdaq:VERU | --- | --- | --- | --- | |------------------------------------------------------------------------------------------|-------|-------|-------| | | | | | | Biopharmaceutical Company Focused on COVID-19 and Oncology | | | | | Veru Corporate Presentation H.C. Wainwright Global Investment Conference May 23-26, 2022 | | | | Forward looking statements The statements in this release that are not historical facts are "forward-looking statements" as that term is defined in the Private Securitie ...

Call End: 09:01 Veru Inc. (NASDAQ:VERU) Q2 2022 Earnings Conference Call May 12, 2022 8:00 AM ET Company Participants Samuel Fisch - Executive Director, Investor Relations and Corporate Communications Mitchell Steiner - Chairman, President and Chief Executive Officer Michele Greco - Chief Financial Officer and Chief Administrative Officer Gary Barnette - Chief Scientific Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Chris Howerton - Jefferies Leland Gershell - Oppenheimer Yi Chen - ...

FORM 10-Q (Mark One) Commission File Number 1-13602 Veru Inc. (Exact Name of Registrant as Specified in its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Wisconsin 39-1144397 (State of Incorporation) (I.R.S. Employer Identification No.) 2916 N. Miami Avenue, Suite 1000, Miami, FL 33127 (Address of Principal Executive Offices) (Zip Code) N/A (Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report) Securities registered pursuant to Section 12(b) of ...

Veru Inc. Nasdaq:VERU | --- | --- | --- | --- | |-------------------------------------------------------------|-------|-------|-------| | | | | | | | | | | | Biopharmaceutical Company Focused on COVID-19 and Oncology | | | | | Veru Corporate Presentation May 2022 | | | | Forward looking statements This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of forward-looking words o ...

Veru Inc. Nasdaq:VERU | --- | --- | --- | --- | |-----------------------------------------------------------------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | Oncology Biopharmaceutical Company Focused on Breast Cancer and Prostate Cancer | | | | | Veru Corporate Presentation Oppenheimer 32nd Annual Healthcare Conference March 15-17, 2022 | | | | Forward looking statements This communication contains forward-looking statements within the meaning of the Private Secu ...